Stockreport

FDA accepts BLA from BeiGene/Novartis for tislelizumab for esophageal cancer [Seeking Alpha]

BeiGene, Ltd. - American Depositary Shares  (BGNE) 
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm Check Earnings Report
PDF FDA accepts BLA from BeiGene/Novartis for tislelizumab for esophageal cancer [Read more]